Urology Coding Alert

How to Ensure Proper Prostate Nodule Diagnosis Coding:

600.x or 239.5?

A urologist performs a prostatic nodule biopsy to determine if the nodule is benign or malignant. But there is no specific ICD-9 code for a prostatic nodule of malignant "potential," says Michael A. Ferragamo, MD, clinical assistant professor of urology at State University of New York, Stony Brook. There are only two codes that represent an unknown etiology a prostate nodule that could be either malignant or benign 236.5 (Neoplasm of uncertain behavior of genitourinary organs; prostate) and 239.5 (Neoplasms of unspecified nature; other genitourinary organs). And although 239.5 is the most appropriate, your carrier may reject it and prefer 236.5 or a benign diagnosis code (600.x, Hyperplasia of prostate). For a prostate biopsy (55700, Biopsy, prostate; needle or punch, single or multiple, any approach), many carriers allow you to use benign prostate nodule codes (600.x) to support medical necessity for the procedure. A prostatic nodule, however, may be a malignant neoplasm (185, Malignant neoplasm of prostate), as determined by the pathologist's analysis of the biopsy specimen. Examining Changes to ICD-9 Two years ago, ICD-9 attempted to clarify the diagnosis codes for these potentially different lesions by increasing the number of codes for benign prostatic disease. But because the prostate nodule codes (600.x) are still defined as benign, ICD-9 still falls short when it comes to codes for prostate biopsies performed for nodules. For many carriers, certain 600.x codes constitute medical necessity for the biopsy and consequently support reimbursement. Using a benign diagnosis code for a biopsy may not make sense because you clearly don't know the nodule's morphology. "But if that is what the carrier wants you to use, use it," says Sandy Page, CPC, co-owner of Medical Practice Support Services in Denver.

In particular, you should check your local medical review policies (LMRPs) to see if you can use 600.9 (Hyperplasia of prostate, unspecified), Page recommends. "Hyperplasia" means growth, and "unspecified" indicates that it could be benign, malignant or of unknown etiology. Although you could make a case for 600.9 being "potentially malignant," it is a nonspecific code, Ferragamo says. Before the new codes were added, urologists used benign prostatic hyperplasia to indicate an enlarged prostate. This diagnosis now has the ICD-9 code 600.0 (Hyperplasia of prostate; hypertrophy [benign] of prostate). Also added at the same time were codes 600.1 ( nodular prostate), 600.2 ( benign localized hyperplasia of prostate), 600.3 ( cyst of prostate) and 600.9. These codes represent a series of benign histological and anatomical lesions. Of the 600.x series, code 600.1 causes the most confusion. According to its ICD-9 definition, it excludes malignant neoplasm of the prostate, so using it to report a lesion being biopsied would be inappropriate. Also, its position in the middle [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Urology Coding Alert

View All